Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Change in Receivables data on record, last reported at $3.0 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 74.09% year-over-year to $3.0 million; the TTM value through Dec 2025 reached -$12.8 million, up 10.75%, while the annual FY2025 figure was -$12.8 million, 10.75% up from the prior year.
  • Change in Receivables reached $3.0 million in Q4 2025 per MRVI's latest filing, up from -$5.1 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $70.8 million in Q1 2021 and bottomed at -$82.4 million in Q1 2023.
  • Average Change in Receivables over 5 years is -$945350.0, with a median of -$2.6 million recorded in 2023.
  • The widest YoY moves for Change in Receivables: up 602.08% in 2021, down 9882.85% in 2021.
  • A 5-year view of Change in Receivables shows it stood at $51.5 million in 2021, then plummeted by 49.99% to $25.8 million in 2022, then crashed by 65.92% to $8.8 million in 2023, then skyrocketed by 30.11% to $11.4 million in 2024, then tumbled by 74.09% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $3.0 million in Q4 2025, -$5.1 million in Q3 2025, and -$501000.0 in Q2 2025.